U.S. flag

An official website of the United States government

NM_004958.4(MTOR):c.6644C>A (p.Ser2215Tyr) AND Renal carcinoma

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 26, 2014
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000441543.9

Allele description [Variation Report for NM_004958.4(MTOR):c.6644C>A (p.Ser2215Tyr)]

NM_004958.4(MTOR):c.6644C>A (p.Ser2215Tyr)

Gene:
MTOR:mechanistic target of rapamycin kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_004958.4(MTOR):c.6644C>A (p.Ser2215Tyr)
Other names:
NM_004958.3(MTOR):c.6644C>A; p.Ser2215Tyr; NM_004958.4(MTOR):c.6644C>A
HGVS:
  • NC_000001.11:g.11124516G>T
  • NG_033239.1:g.143036C>A
  • NM_004958.4:c.6644C>AMANE SELECT
  • NP_004949.1:p.Ser2215Tyr
  • LRG_734t1:c.6644C>A
  • LRG_734:g.143036C>A
  • NC_000001.10:g.11184573G>T
  • NM_004958.3:c.6644C>A
Protein change:
S2215Y; SER2215TYR
Links:
OMIM: 601231.0005; dbSNP: rs587777894
NCBI 1000 Genomes Browser:
rs587777894
Molecular consequence:
  • NM_004958.4:c.6644C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Renal carcinoma
Synonyms:
Kidney Carcinoma
Identifiers:
MONDO: MONDO:0005206; MedGen: C1378703

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000505139Database of Curated Mutations (DoCM)
no assertion criteria provided
Likely pathogenic
(Dec 26, 2014)
somaticliterature only

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.

Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM.

Cancer Discov. 2014 May;4(5):554-63. doi: 10.1158/2159-8290.CD-13-0929. Epub 2014 Mar 14.

PubMed [citation]
PMID:
24631838
PMCID:
PMC4012430

Details of each submission

From Database of Curated Mutations (DoCM), SCV000505139.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024